// App-Quantinova.ai

e13585 : A precision dosing application for prostate cancer patients treated with docetaxel and G-CSF.

Researchers

Presenter

  • Claire Villette

Principal Investigators

  • Christian Hurry

  • Hitesh Mistry

  • Jim Millen

  • Christophe Chassagnole

Medical Centers

  • Physiomics Plc, Oxford, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Granulocyte colony-stimulating factor

  • Chromosomal instability

Drug/Treatment

  • Docetaxel

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT00617669

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved